Low-intensity focused ultrasound to see if it can boost thinking in healthy adults
Official title: Cognition and Ultrasound
Run by University of Minnesota · NCT07220655 · Data updated 2026-11-12
This trial will use low-intensity focused ultrasound on deep brain targets to see if it can improve thinking and memory in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Minnesota Academic / other |
| Locations | 1 site (Minneapolis, Minnesota) |
| Status | Recruiting |
| Started | June 1, 2024 |
| Main results expected | July 1, 2028 |
| Study ends | July 1, 2028 |
| Registry record updated | June 15, 2026 |
| Trial ID | NCT07220655 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who speak English, are healthy with no neurologic disorder, are not taking psychoactive medications, are not pregnant, and can safely undergo MRI are ideal candidates.
✕Probably not a fit
People with neurological disorders, most psychiatric diagnoses, those taking psychoactive medications, pregnant people, or anyone unable to have an MRI may not receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-site interventional trial uses low-intensity focused ultrasound (LIFU) to noninvasively target deep brain regions while participants undergo brain imaging and cognitive testing. Healthy adults who can complete MRI scans and are not taking psychoactive medications will receive LIFU sessions and standardized tests of attention, memory, and other cognitive functions. Participants with neurological disorders, most psychiatric diagnoses, pregnancy, or MRI contraindications are excluded to reduce risk and variability. The goal is to link changes in brain activity measured by fMRI with any short-term changes in cognitive performance.
Why it matters
Potential benefit: If successful, this approach could point to a noninvasive way to temporarily improve certain aspects of thinking and memory or guide future therapies.
How similar studies have gone: Early pilot studies have shown LIFU can modulate brain activity, but clear and consistent cognitive benefits in humans remain preliminary and unproven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Speak English (as assessed by their ability to read/answer survey questions) * May be required to score in the appropriate range on self-report measures Exclusion Criteria: * They have a neurological disorder which may impact their fMRI scan or cause their reaction to LIFU to differ from that of healthy adults. * They take any psychoactive medication. * They are unable to undergo fMRI scanning due to a contraindication such as claustrophobia, unremovable piercings, pregnancy, the presence of medical devices such as pacemakers, or a movement or sleep disorder. * Are pregnant, or may have reason to believe that they are pregnant. * They have a diagnosis of a psychiatric condition other than depression or anxiety
Where it's running
-
University of Minnesota
Minneapolis, Minnesota, United States Recruiting
Study contacts
- Principal investigator: Michael Bronstein — University of Minnesota
- Study coordinator: Miriam Freedman
- Email: bronsteinlab@umn.edu
- Phone: tel:612-625-3330
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How age affects germinal center responses after flu and rabies vaccines
Researchers will test how the immune system responds to flu and rabies vaccines in younger adults (18–40) and older adults (65+).
-
Magnetic field maps with NV sensors for non-invasive heart measurements
This study tests whether diamond-based NV magnetometers can non-invasively detect and map the heart's magnetic field in healthy adults.
-
Methylation analyses using home-based self-sampling in women with and without gynecological disease
This study tests whether self-collected urine and vaginal samples can reveal DNA methylation markers that distinguish people with gynecological (pre-)cancers from cancer-free controls.
-
Omega-3 status in healthy adults: comparing different fish-oil and algae-oil products
This study tests whether various fish-oil and algae-oil products can raise the Omega-3 Index in healthy adults who don’t eat much fatty fish.
-
A safe, carefully dosed test of TBD11 in healthy adults
This phase 1 study tests TBD11 in healthy adults to see if it is safe and tolerable and to understand how it behaves in the body, including how it interacts with other medicines.
-
Fosmanogepix in healthy adults: how it may interact with other drugs and heart rhythm
This study tests whether fosmanogepix (and its active form manogepix) changes how other medicines work in healthy adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.